No abstract available
Keywords:
Duchenne muscular dystrophy; FDA; gene therapy; regulatory.
MeSH terms
-
Drug Approval*
-
Genetic Therapy
-
Humans
-
Muscular Dystrophy, Duchenne* / drug therapy
-
Muscular Dystrophy, Duchenne* / genetics
-
United States
-
United States Food and Drug Administration*